Increasing Investments in Cell-based Research Spurs Growth in the Global Cell-based Assays Market, According to New Report by Global Industry Analysts, Inc.

Share Article

GIA announces the release of a comprehensive global report on Cell-based Assays markets. Global market for Cell-based Assays is projected to reach US$27 billion by the year 2020, driven by rising investments in cell-based research.

Cell-based Assays: A Global Strategic Business Report

Follow us on LinkedIn – Cell-based assays are experiments conducted on live cells, and comprise various types of assays for the quantification of cell morphology, proliferation, motility, toxicity, and cell death. Pharmaceutical and biotech companies, academic and government institutions, contract research organizations (CROs), hospitals, clinical labs and environmental labs are major end-users of cell-based assays. Cell-based assays continue to find commercial success owing to the advantages offered when compared to traditional biochemical assays and animal models. The market is expected to benefit immensely from expanding application markets and increasing number of public-private partnerships in support of cell-based research activities. Growth is also driven by the rising need for drug development companies to expand their drug portfolios. Cell-based assays play a pivotal role in enhancing the understanding of the behavior and biology of cells, and in turn play an indispensable role in the development and launch of new drugs. Given that late-stage failures translate into huge losses, cell-based assays hold great potential in the drug discovery process, due to its ability to analyze and understand response of live cells to potential compounds in early drug developmental stages.

Automation, use of microfluidics systems, increasing use in toxicity testing, non-invasive monitoring of cell-based assays, and the development of label-free cell-based assays are some of the notable trends in the market. The market is also witnessing spurt in demand for comparative, immunogenicity and neutralizing antibody assays, led by increasing interest of pharmaceutical industry participants in predictive cell toxicity testing. High-content screening (HCS) technologies are rapidly emerging as promising detection techniques in cell-based assays, given their ability to study detailed cellular mechanisms in a biologically relevant context.

As stated by the new market research report on Cell-based Assays, the United States represents the single largest market worldwide, with growth supported by the presence of state-of-the-art biotech labs and active participation of several players ranging from pharmaceutical companies to research-oriented niche companies. Europe is forecast to emerge as the fastest growing market with a CAGR of 16.3% over the forecast period. Emerging economies of China and India will also exhibit strong growth, as these countries emerge as favorable destinations for outsourced pharmaceutical R&D activities.

Key players covered in the report include BD Biosciences, Beckman Coulter Inc., BioVision Inc., Cisbio Bioassays, DiscoveRx Corporation, EMD Millipore Corp., Enzo Life Sciences Inc., Evotec AG, GE Healthcare Life Sciences, New England Biolabs Inc., PerkinElmer Inc., Promega Corporation, ProQinase GmbH, Qiagen NV, Sigma-Aldrich Corporation, StemCells Inc., Life Technologies Corp., and Xenometrix AG.

The research report titled “Cell-based Assays: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, issues, drivers, mergers, acquisitions and other strategic industry activities. The report provides market estimates and projections in dollars for all major geographic markets such as the United States, Japan, Europe (France, Germany, Italy, UK, Spain and Rest of Europe), and Rest of World. Application markets analyzed include Basic Research, ADME Testing, and Drug Discovery.

For more details about this comprehensive market research report, please visit –

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes 1500+ full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site:


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Public Relations
Visit website